FDA Authorizes Moderna’s coronavirus vaccines for emergency use

On Friday, the U.S Food and Drug Administration formally authorized Moderna’s Coronavirus Vaccine for emergency use. Modern’s Covid-19 vaccine becomes second to get authorization from FDA.

Just one week earlier Pfizer and BioNTech’s COVID-19 vaccine earned authorization for emergency use.

In a press release, FDA Commissioner Dr. Stephen M. Hahn said- “With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing vast numbers of hospitalizations and deaths in the United States each day.”

Today, FDA issued an emergency use authorization (EUA) for the second vaccine for the prevention of #COVID19 caused by SARS-CoV-2. The emergency use authorization allows the vaccine to be distributed in the U.S for use in individuals 18 years and older. https://t.co/w4BQVg0n2G pic.twitter.com/cw5JwYqxsh
— U.S. FDA (@US_FDA) December 19, 2020

Read FDA’s Press Announcements

Comments